| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2402029
Max Phase: Preclinical
Molecular Formula: C18H19NO6
Molecular Weight: 345.35
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1ccc2c(c1)oc(=O)n2Cc1cc(OC)c(OC)c(OC)c1
Standard InChI: InChI=1S/C18H19NO6/c1-21-12-5-6-13-14(9-12)25-18(20)19(13)10-11-7-15(22-2)17(24-4)16(8-11)23-3/h5-9H,10H2,1-4H3
Standard InChI Key: PUORVQNHIQNFOG-UHFFFAOYSA-N
Associated Targets(Human)
MDA-MB-231 73002 Activities
PC-3 62116 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Tubulin 1327 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 345.35 | Molecular Weight (Monoisotopic): 345.1212 | AlogP: 2.68 | #Rotatable Bonds: 6 |
| Polar Surface Area: 72.06 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.29 | CX LogD: 2.29 |
| Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.68 | Np Likeness Score: -0.68 |
References
| 1. Sun Y, Pandit B, Chettiar SN, Etter JP, Lewis A, Johnsamuel J, Li PK.. (2013) Design, synthesis and biological studies of novel tubulin inhibitors., 23 (15): [PMID:23790539] [10.1016/j.bmcl.2013.04.078] |
Source
Source(1):